SS/Jr |
receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio |
Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 12 |
50.61 |
% |
5.29 |
18.33 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69069 |
1096 |
SS/Jr |
blood vessel contractile force measurement |
Kreb's solution perfusate then potassium chloride solution (40 mmol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 12 |
1.59 |
g |
0.11 |
0.38 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
|
|
69048 |
1096 |
SS/Jr |
blood vessel contractile force measurement |
Kreb's solution perfusate then potassium chloride solution (40 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 12 |
1.39 |
g |
0.06 |
0.21 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69050 |
1096 |
SS/Jr |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
Kreb's solution perfusate then phenylephrine (1-100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 12 |
-7.6 |
null |
0.05 |
0.17 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
EC50 value is probably moles/liter |
69058 |
1096 |
SS/Jr |
logarithm of the concentration of angiotensin II at which the force of blood vessel contraction is half the maximum value (Log EC50) |
Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) then NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 12 |
-7.92 |
null |
0.36 |
1.25 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69071 |
1096 |
SS/Jr |
receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio |
Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 12 |
34.85 |
% |
2.94 |
10.18 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69065 |
1096 |
SS/Jr |
logarithm of the concentration of angiotensin II at which the force of blood vessel contraction is half the maximum value (Log EC50) |
Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 12 |
-8.22 |
null |
0.26 |
0.9 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69067 |
1096 |
SS/Jr |
receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio |
Kreb's solution perfusate then phenylephrine (1-100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 12 |
141.72 |
% |
7.73 |
26.78 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69056 |
1096 |
SS/Jr |
receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio |
Kreb's solution perfusate then phenylephrine (1-100 mmol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 12 |
104.06 |
% |
4.7 |
16.28 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69052 |
1096 |
SS/Jr |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
Kreb's solution perfusate then phenylephrine (1-100 mmol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 12 |
-7.26 |
null |
0.06 |
0.21 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
EC50 value is probably moles/liter |
69054 |
1096 |